Description
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, making it a subject of significant interest in metabolic research and body composition studies. 5mg vial, pharmaceutical-grade purity.
For research purposes only. Not for human consumption. This product is intended for laboratory research use.

Reviews
There are no reviews yet.